• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

冠状动脉疾病中的活化及总凝血因子VII和纤维蛋白原。

Activated and total coagulation factor VII, and fibrinogen in coronary artery disease.

作者信息

Danielsen R, Onundarson P T, Thors H, Vidarsson B, Morrissey J H

机构信息

Department of Medicine, Landspítalinn, University Hospital, Reykjavik, Iceland.

出版信息

Scand Cardiovasc J. 1998;32(2):87-95. doi: 10.1080/14017439850140238.

DOI:10.1080/14017439850140238
PMID:9636964
Abstract

Fibrinogen (FBG) and total coagulation factor VII (FVIIc) concentrations are higher in those patients with coronary artery disease who are at increased future risk of acute ischemic events. The relationship between activated factor VII (FVIIa) and cardiovascular events, however, has not been intensively studied. Data were collected from 401 consecutive patients who underwent coronary angiography because of suspected coronary artery disease. Conventional risk factors FVIIc, FVIIa and FBG were assessed in relation to the severity of coronary artery disease, left ventricular ejection fraction, and previous clinical events. A strong positive correlation was found between FVIIa and FVIIc (p < 0.001), but neither FVIIa nor FVIIc correlated with FBG. No correlation was found between FVIIa, FVIIc or FBG levels and stenosis score for the severity of coronary artery disease, and all were similar in patients with stable or unstable angina pectoris. Multivariate regression analysis showed FVIIc to be higher in women (p = 0.004), and positively related to triglycerides (p = 0.001) and HDL cholesterol (p = 0.006), but not to a previous myocardial infarction or total cholesterol. FVIIa, on the other hand, was lower in patients with a previous myocardial infarction (p = 0.004), higher in women (p = 0.001) and those that previously had undergone percutaneous transluminal coronary angioplasty (p = 0.039), and positively related to total cholesterol (p = 0.011), duration of coronary artery disease (p = 0.032), and smoking (p = 0.008). FBG was positively associated with a previous myocardial infarction (p = 0.013), hypertension (p = 0.016), smoking (p = 0.005), and the thrombocyte count (p < 0.001). Finally, stepwise logistic regression analysis verified a previous myocardial infarction to be negatively associated with FVIIa (p = 0.03), and positively with FBG (p = 0.03), total cholesterol (p = 0.02), and the severity of coronary artery disease (p < 0.001). In conclusion, in patients suspected of coronary artery disease undergoing cardiac catheterization, FVIIa was decreased and FBG increased in those who had a previous myocardial infarction. FVIIa, FVIIc, or FBG levels were not, however, related to the severity of coronary artery disease, and they were similar in patients with stable or unstable angina pectoris.

摘要

在那些未来发生急性缺血事件风险增加的冠心病患者中,纤维蛋白原(FBG)和总凝血因子VII(FVIIc)浓度较高。然而,活化因子VII(FVIIa)与心血管事件之间的关系尚未得到深入研究。数据收集自401例因疑似冠心病接受冠状动脉造影的连续患者。评估了传统危险因素FVIIc、FVIIa和FBG与冠状动脉疾病严重程度、左心室射血分数及既往临床事件的关系。发现FVIIa与FVIIc之间存在强正相关(p < 0.001),但FVIIa和FVIIc与FBG均无相关性。未发现FVIIa、FVIIc或FBG水平与冠状动脉疾病严重程度的狭窄评分之间存在相关性,且在稳定型或不稳定型心绞痛患者中所有这些指标均相似。多因素回归分析显示,女性的FVIIc较高(p = 0.004),且与甘油三酯(p = 0.001)和高密度脂蛋白胆固醇(p = 0.006)呈正相关,但与既往心肌梗死或总胆固醇无关。另一方面,既往有心肌梗死的患者FVIIa较低(p = 0.004),女性及既往接受过经皮腔内冠状动脉成形术的患者FVIIa较高(p = 0.039),且FVIIa与总胆固醇(p = 0.011)、冠状动脉疾病病程(p = 0.032)及吸烟(p = 0.008)呈正相关。FBG与既往心肌梗死(p = 0.013)、高血压(p = 0.016)、吸烟(p = 0.005)及血小板计数(p < 0.001)呈正相关。最后,逐步逻辑回归分析证实既往心肌梗死与FVIIa呈负相关(p = 0.03),与FBG、总胆固醇(p = 0.02)及冠状动脉疾病严重程度呈正相关(p < 0.001)。总之,在接受心脏导管检查的疑似冠心病患者中,既往有心肌梗死的患者FVIIa降低而FBG升高。然而,FVIIa、FVIIc或FBG水平与冠状动脉疾病严重程度无关,且在稳定型或不稳定型心绞痛患者中相似。

相似文献

1
Activated and total coagulation factor VII, and fibrinogen in coronary artery disease.冠状动脉疾病中的活化及总凝血因子VII和纤维蛋白原。
Scand Cardiovasc J. 1998;32(2):87-95. doi: 10.1080/14017439850140238.
2
Factor VII and fibrinogen levels examined by age, sex, and other atherosclerotic risk factors in a Japanese population. The Jichi Medical School Cohort Study.在日本人群中按年龄、性别及其他动脉粥样硬化危险因素检测因子VII和纤维蛋白原水平。自治医科大学队列研究。
Thromb Haemost. 1997 May;77(5):890-3.
3
Coagulation factor VII and the risk of coronary heart disease in healthy men.凝血因子VII与健康男性患冠心病的风险
Arterioscler Thromb Vasc Biol. 1997 Aug;17(8):1539-44. doi: 10.1161/01.atv.17.8.1539.
4
Population correlates of coagulation factor VII. Importance of age, sex, and menopausal status as determinants of activated factor VII.凝血因子VII与人群的相关性。年龄、性别和绝经状态作为活化因子VII决定因素的重要性。
Arterioscler Thromb Vasc Biol. 1996 Sep;16(9):1170-6. doi: 10.1161/01.atv.16.9.1170.
5
Fluorogenic assay of activated factor VII. Plasma factor VIIa levels in relation to arterial cardiovascular diseases in Japanese.活化因子VII的荧光测定。日本人血浆中因子VIIa水平与动脉心血管疾病的关系。
Arterioscler Thromb. 1994 Feb;14(2):265-74. doi: 10.1161/01.atv.14.2.265.
6
Role of coagulation factor VII in pathogenesis of ischemic heart disease.凝血因子VII在缺血性心脏病发病机制中的作用。
J Huazhong Univ Sci Technolog Med Sci. 2006;26(6):657-60. doi: 10.1007/s11596-006-0607-3.
7
Levels of factor VIIc associated with decreased tissue factor pathway inhibitor and increased plasminogen activator inhibitor-1 in dyslipidemias.血脂异常中,凝血因子VIIc水平与组织因子途径抑制物降低及纤溶酶原激活物抑制物-1升高相关。
Arterioscler Thromb Vasc Biol. 1996 Jan;16(1):77-81. doi: 10.1161/01.atv.16.1.77.
8
Fibrinogen, coagulation factor VII, tissue plasminogen activator, plasminogen activator inhibitor-1, and lipid as cardiovascular risk factors in chronic hemodialysis and continuous ambulatory peritoneal dialysis patients.纤维蛋白原、凝血因子VII、组织型纤溶酶原激活剂、纤溶酶原激活剂抑制剂-1以及脂质作为慢性血液透析和持续性非卧床腹膜透析患者的心血管危险因素。
Am J Kidney Dis. 1996 Jun;27(6):848-54. doi: 10.1016/s0272-6386(96)90523-5.
9
The pre-existence of an acute coronary event predicts differences in biological parameters and clinical evolution among patients with longstanding stable angina.急性冠状动脉事件的既往史可预测长期稳定型心绞痛患者生物学参数及临床病程的差异。
Int J Cardiol. 2003 Oct;91(2-3):193-200. doi: 10.1016/s0167-5273(03)00028-7.
10
The strong positive correlation between factor VII clotting activity using bovine thromboplastin and the activated factor VII level.使用牛凝血活酶的凝血因子VII凝血活性与活化凝血因子VII水平之间存在强正相关。
Thromb Haemost. 1995 Mar;73(3):429-34.

引用本文的文献

1
Factor VII and incidence of myocardial infarction in a Japanese population: The Jichi Medical School Cohort Study.日本人群中凝血因子VII与心肌梗死发病率:自治医科大学队列研究
J Clin Lab Anal. 2017 Nov;31(6). doi: 10.1002/jcla.22133. Epub 2017 Feb 13.
2
How it all starts: Initiation of the clotting cascade.这一切是如何开始的:凝血级联反应的启动。
Crit Rev Biochem Mol Biol. 2015;50(4):326-36. doi: 10.3109/10409238.2015.1050550. Epub 2015 May 28.
3
Investigation of tissue factor and other hemostatic profiles in experimental hypothyroidism.
实验性甲状腺功能减退症中组织因子及其他止血指标的研究
Endocrine. 2006 Aug;30(1):63-7. doi: 10.1385/ENDO:30:1:63.
4
Acute coronary syndromes: should women receive less antithrombotic medication than men?急性冠状动脉综合征:女性接受的抗血栓药物治疗应比男性少吗?
Heart. 2004 Apr;90(4):363-6. doi: 10.1136/hrt.2002.003483.
5
Levels of serum IL-1beta, IL-2, IL-8 and tumor necrosis factor-alpha in patients with unstable angina pectoris.不稳定型心绞痛患者血清白细胞介素-1β、白细胞介素-2、白细胞介素-8和肿瘤坏死因子-α水平
Mediators Inflamm. 2003 Dec;12(6):361-5. doi: 10.1080/09629350310001633360.
6
Fibrinogen and coronary risk.纤维蛋白原与冠心病风险。
Curr Cardiol Rep. 1999 Jul;1(2):112-8. doi: 10.1007/s11886-999-0068-y.